SCHEMBL4185534

SCHEMBL4185534

COC(=O)COc1ccc(/C=C/C2CCN(C(=O)OC(C)(C)C)CC2)cc1[N+](=O)[O-]

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
GPR119 Q8TDV5 2/20 0.38
PTGS2 P35354 1/20 0.38
STS P08842 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 4/20 0.38
LMNA P02545 1/20 0.38
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
KDM4E B2RXH2 2/20 0.38
APP P05067 1/20 0.38
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
PDE4D Q08499 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4185542 1.00 ALDH1A1 (0.39) ALDH1A1GPR119PTGS2STSSMN1; SMN2
SCHEMBL4190114 0.88 ALDH1A1 (0.43) ALDH1A1PTGS2SMN1; SMN2KMT2ANPC1
SCHEMBL4190117 0.88 ALDH1A1 (0.43) ALDH1A1PTGS2SMN1; SMN2KMT2ANPC1
SCHEMBL4190120 0.88 ALDH1A1 (0.43) ALDH1A1PTGS2SMN1; SMN2KMT2ANPC1
SCHEMBL13927876 0.86 LMNA (0.44) ALDH1A1PTGS2SMN1; SMN2KMT2ANPC1
SCHEMBL13927920 0.83 PTGS2 (0.40) ALDH1A1PTGS2SMN1; SMN2KMT2ANPC1
SCHEMBL25368200 0.83 STS (0.42) ALDH1A1GPR119STSSMN1; SMN2KMT2A
SCHEMBL4187138 0.82 ALDH1A1 (0.43) ALDH1A1GPR119NPC1RAB9AMAPT
SCHEMBL4187142 0.82 ALDH1A1 (0.43) ALDH1A1GPR119NPC1RAB9AMAPT
SCHEMBL5362064 0.81 ALDH1A1 (0.50) ALDH1A1GPR119STSSMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090042874-A1 ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS WYETH (US) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042874-A1 ANTIDEPRESSANT HETEROARYL DERIVATIVES OF HETEROCYCLE-FUSED BENZODIOXANS HTR5A, CRH, CYP17A1 ALDH1A1 643/4885GPR119 100/4885PTGS2 3128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.